+

WO2002006469A3 - Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids - Google Patents

Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids Download PDF

Info

Publication number
WO2002006469A3
WO2002006469A3 PCT/US2001/022640 US0122640W WO0206469A3 WO 2002006469 A3 WO2002006469 A3 WO 2002006469A3 US 0122640 W US0122640 W US 0122640W WO 0206469 A3 WO0206469 A3 WO 0206469A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligonucleotides
populations
methods
nucleic acids
population
Prior art date
Application number
PCT/US2001/022640
Other languages
French (fr)
Other versions
WO2002006469A2 (en
Inventor
Wayne M Coco
Lance P Encell
Joseph J Arensdorf
Original Assignee
Enchira Biotechnology Corp
Wayne M Coco
Lance P Encell
Joseph J Arensdorf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enchira Biotechnology Corp, Wayne M Coco, Lance P Encell, Joseph J Arensdorf filed Critical Enchira Biotechnology Corp
Priority to AU2001273559A priority Critical patent/AU2001273559A1/en
Publication of WO2002006469A2 publication Critical patent/WO2002006469A2/en
Publication of WO2002006469A3 publication Critical patent/WO2002006469A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1031—Mutagenizing nucleic acids mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention is drawn to a method for forming at least one chimeric polynucleotide, methods for directed evolution, chimeric polynucleotides and libraries of chimeric polynucleotides. One method comprises contacting a first population of single-stranded oligonucleotides wherein the oligonucleotides share minimal complementarity with each other with a second population of oligonucleotides, under conditions wherein the oligonucleotides of the first and second populations hybridize to each other, forming at least one hybridized complex, comprising at least one polynucleotide from the first population hybridized to at least two oligonucleotides from the second population. Single-stranded regions are filled in using polymerase. The filled-in hybridized complex is treated such that the adjacent nucleic acids are ligated, forming at least one chimeric polynucleotide.
PCT/US2001/022640 2000-07-18 2001-07-18 Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids WO2002006469A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001273559A AU2001273559A1 (en) 2000-07-18 2001-07-18 Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US21892100P 2000-07-18 2000-07-18
US21908500P 2000-07-18 2000-07-18
US60/219,085 2000-07-18
US60/218,921 2000-07-18
US69273200A 2000-10-19 2000-10-19
US69187300A 2000-10-19 2000-10-19
US09/692,732 2000-10-19
US09/691,873 2000-10-19

Publications (2)

Publication Number Publication Date
WO2002006469A2 WO2002006469A2 (en) 2002-01-24
WO2002006469A3 true WO2002006469A3 (en) 2002-08-15

Family

ID=27499132

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/022640 WO2002006469A2 (en) 2000-07-18 2001-07-18 Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids

Country Status (2)

Country Link
AU (1) AU2001273559A1 (en)
WO (1) WO2002006469A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951719B1 (en) 1999-08-11 2005-10-04 Proteus S.A. Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained
US6991922B2 (en) 1998-08-12 2006-01-31 Proteus S.A. Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation
US20030036641A1 (en) * 2001-01-31 2003-02-20 Padgett Hal S. Methods for homology-driven reassembly of nucleic acid sequences
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
GB2388604B (en) * 2002-05-17 2005-01-26 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
SI2345671T1 (en) 2002-09-27 2016-03-31 Xencor Inc. Optimized fc variants and methods for their generation
AU2003279089A1 (en) * 2002-09-30 2004-04-19 Parallele Bioscience, Inc. Polynucleotide synthesis and labeling by kinetic sampling ligation
EP1613661B1 (en) * 2003-04-04 2011-06-29 Université de Lausanne Peptabody for cancer treatment
US8883147B2 (en) 2004-10-21 2014-11-11 Xencor, Inc. Immunoglobulins insertions, deletions, and substitutions
US8399618B2 (en) 2004-10-21 2013-03-19 Xencor, Inc. Immunoglobulin insertions, deletions, and substitutions
CA2548817A1 (en) 2003-12-04 2005-06-23 Xencor, Inc. Methods of generating variant proteins with increased host string content and compositions thereof
WO2005092925A2 (en) 2004-03-24 2005-10-06 Xencor, Inc. Immunoglobulin variants outside the fc region
WO2006053301A2 (en) 2004-11-12 2006-05-18 Xencor, Inc. Fc variants with altered binding to fcrn
PL1772465T3 (en) 2005-01-05 2009-08-31 F Star Biotechnologische Forschungs Und Entw M B H Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
GB0500703D0 (en) * 2005-01-14 2005-02-23 Bioinvent Int Ab Molecular biology method
AT503889B1 (en) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F MULTIVALENT IMMUNE LOBULINE
ES2975748T3 (en) 2007-06-26 2024-07-12 F Star Therapeutics Ltd Presentation of bonding agents
US7682809B2 (en) 2008-01-11 2010-03-23 Agilent Technologies, Inc. Direct ATP release sequencing
EP2113255A1 (en) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Cytotoxic immunoglobulin
AU2016321204B2 (en) 2015-09-08 2022-12-01 Cold Spring Harbor Laboratory Genetic copy number determination using high throughput multiplex sequencing of smashed nucleotides

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016090A1 (en) * 1993-01-15 1994-07-21 Molecular Tool, Inc. Method for generating single-stranded dna molecules
WO1995022625A1 (en) * 1994-02-17 1995-08-24 Affymax Technologies N.V. Dna mutagenesis by random fragmentation and reassembly
WO1998001581A1 (en) * 1996-07-09 1998-01-15 Recombinant Biocatalysis, Inc. Method of dna shuffling with polynucleotides produced by blockingor interrupting a synthesis or amplification process
WO1998027230A1 (en) * 1996-12-18 1998-06-25 Maxygen, Inc. Methods and compositions for polypeptide engineering
WO1998042832A1 (en) * 1997-03-25 1998-10-01 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
FR2782323A1 (en) * 1998-08-12 2000-02-18 Proteus In vitro recombination of polynucleotide fragments to obtain sequences with improved properties involves ligation on an assembly matrix
WO2000042561A2 (en) * 1999-01-19 2000-07-20 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
WO2001029212A1 (en) * 1999-10-19 2001-04-26 Enchira Biotechnology Corporation Methods for chimeragenesis of whole genomes or large polynucleotides
WO2001029211A2 (en) * 1999-10-19 2001-04-26 Enchira Biotechnology Corporation Method for directed evolution by random chimeragenesis on transient templates

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016090A1 (en) * 1993-01-15 1994-07-21 Molecular Tool, Inc. Method for generating single-stranded dna molecules
WO1995022625A1 (en) * 1994-02-17 1995-08-24 Affymax Technologies N.V. Dna mutagenesis by random fragmentation and reassembly
WO1998001581A1 (en) * 1996-07-09 1998-01-15 Recombinant Biocatalysis, Inc. Method of dna shuffling with polynucleotides produced by blockingor interrupting a synthesis or amplification process
WO1998027230A1 (en) * 1996-12-18 1998-06-25 Maxygen, Inc. Methods and compositions for polypeptide engineering
WO1998042832A1 (en) * 1997-03-25 1998-10-01 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
WO1998042728A1 (en) * 1997-03-25 1998-10-01 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
FR2782323A1 (en) * 1998-08-12 2000-02-18 Proteus In vitro recombination of polynucleotide fragments to obtain sequences with improved properties involves ligation on an assembly matrix
WO2000042561A2 (en) * 1999-01-19 2000-07-20 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
WO2001029212A1 (en) * 1999-10-19 2001-04-26 Enchira Biotechnology Corporation Methods for chimeragenesis of whole genomes or large polynucleotides
WO2001029211A2 (en) * 1999-10-19 2001-04-26 Enchira Biotechnology Corporation Method for directed evolution by random chimeragenesis on transient templates

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
COCO W M ET AL: "A NOVEL METHOD FOR SHUFFLING CHIMERAGENESIS OF MUTATED GENES OR OF GENE FAMILIES FROM DIVERGENT BACTERIAL GENERA", ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, vol. 100, 22 May 2000 (2000-05-22), pages 497, XP000990036, ISSN: 0067-2777 *
CRAMERI A ET AL: "DNA SHUFFLING OF A FAMILY OF GENES FROM DIVERSE SPECIES ACCELERATESDIRECTED EVOLUTION", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 391, 15 January 1998 (1998-01-15), pages 288 - 291, XP000775869, ISSN: 0028-0836 *
KIKUCHI M ET AL: "Novel family shuffling methods for the in vitro evolution of enzymes", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 236, no. 1, 5 August 1999 (1999-08-05), pages 159 - 167, XP004175459, ISSN: 0378-1119 *
KUCHNER AND F H ARNOLD A: "Directed evolution of enzyme catalysts", TRENDS IN BIOTECHNOLOGY, ELSEVIER, AMSTERDAM,, GB, vol. 15, no. 12, December 1997 (1997-12-01), pages 523 - 530, XP002133872, ISSN: 0167-7799 *
SHAO ZHIXIN ET AL: "Random-priming in vitro recombination: An effective tool for directed evolution", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 26, no. 2, 15 January 1998 (1998-01-15), pages 681 - 683, XP002162556, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
AU2001273559A1 (en) 2002-01-30
WO2002006469A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
WO2002006469A3 (en) Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids
EP1003915B8 (en) Amplification of nucleic acids
WO2003040366A3 (en) Inhibitor oligonucleotides and their use for specific repression of a gene
WO2004029223A3 (en) Polynucleotide synthesis and labeling by kinetic sampling ligation
HK1033946A1 (en) Oligonucleotide analogues
FI3872187T3 (en) Compositions and methods for improving sample identification in indexed nucleic acid libraries
WO1999010358A3 (en) Method for producing nucleic acid polymers
HK1044803B (en) Nucleic acid ligand inhibitors to dna polymerases
WO2002036832A3 (en) Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis
EP1007655A4 (en) RNASE L ACTIVATORS AND ANTISENSE OLIGONUCLEOTIDES EFFECTIVE IN THE TREATMENT OF RSV INFECTIONS
EP2017356A8 (en) Tagged oliggonucleotides and their use in nucleic acid amplification methods
WO2003044216A3 (en) Multiplex oligonucleotide addition and target amplification
GB9620075D0 (en) Method
PT833944E (en) Nucleic acid ligands that bind to and inhibit dna polymerases
NO933136D0 (en) DETERMINATION OF NUCLEIC ACIDS BY POLYMERASE EXTENSION OF OLIGON NUCLEOTIDES USING TERMINATOR MIXTURES
EP0665293A3 (en) Method of determining base sequence of nucleic acid
DE50007314D1 (en) METHOD FOR CONTROLLING THE PERFORMANCE OF COMPLEX PCR AMPLIFICATIONS
WO2006125447A3 (en) Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina
US6403340B1 (en) Template chain reaction
FI3668994T3 (en) Method of detection of dna end(s) and its use
WO2001023618A3 (en) Compositions and methods for reducing oligonucleotide hybridization and priming specificity
WO2002010458A3 (en) Method of performing subtractive hybridization
Guieysse et al. Inhibition of replication initiation by triple helix-forming oligonucleotides
ATE165870T1 (en) METHOD FOR AMPLIFICATION AND/OR DETECTION OF A NUCLEIC ACID SEQUENCE, DETECTION REAGENT AND USES THEREOF
EP1221491B8 (en) SUSPENSION SYSTEM FOR SEQUENCING GENETIC SUBSTANCE, METHOD OF SEQUENCING GENETIC SUBSTANCE BY USING THE SUSPENSION SYSTEM, AND METHOD OF HIGH-SPEED SNPs SCORING BY USING THE SUSPENSION SYSTEM

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
ENP Entry into the national phase

Country of ref document: RU

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载